Is ENZC or XYLD a better dividend investment in 2026?

ENZC currently yields 500000.00% with a 5% 5-year dividend growth rate. XYLD yields 10.98% with 0.5% growth. The better choice depends on your goal: ENZC offers higher current income.

What is the dividend yield difference between ENZC and XYLD?

ENZC has a forward dividend yield of 500000.00% ($2.00/share annually). XYLD yields 10.98% ($4.30/share annually). The yield gap is 499989.02 percentage points.

Home › Compare › ENZC vs XYLD

ENZC vs XYLD: Dividend Comparison 2026

ENZC yields 500000.00% · XYLD yields 10.98%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ENZC wins by $4.663521010693878e+33M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ENZC

● Live price

500000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.663521010693878e+33M

Annual income

$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00

Full ENZC calculator →

XYLD

Global X S&P 500 Covered Call ETF

● Live price

10.98%

Share price

$39.13

Annual div

$4.30

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.3K

Annual income

$3,219.02

Full XYLD calculator →

Portfolio growth — ENZC vs XYLD

📍 ENZC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ENZC	XYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ENZC + XYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ENZC pays

XYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ENZC

Annual income on $10K today (after 15% tax)

$42,500,000.00/yr

After 10yr DRIP, annual income (after tax)

$3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/yr

XYLD

Annual income on $10K today (after 15% tax)

$933.63/yr

After 10yr DRIP, annual income (after tax)

$2,736.17/yr

At 15% tax rate, ENZC beats the other by $3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ENZC + XYLD for your $10,000?

ENZC: 50%XYLD: 50%

100% XYLD50/50100% ENZC

Portfolio after 10yr

$2.331760505346939e+33M

Annual income

$2,330,843,480,963,498,000,000,000,000,000,000,000,000.00/yr

Blended yield

99.96%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ENZC buys

XYLD buys

No recent congressional trades found for ENZC or XYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricENZCXYLD

Forward yield	500000.00% ✓	10.98%
Annual dividend / share	$2.00	$4.30 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$4.663521010693878e+33M	$25.3K ✓
Annual income after 10y	$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00 ✓	$3,219.02
Total dividends collected	$4.6634009849658873e+33M	$19.6K ✓
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: ENZC vs XYLD ($10,000, DRIP)

Year	ENZC Portfolio	ENZC Income/yr	XYLD Portfolio	XYLD Income/yr	Gap
1← crossover	$50,010,700	$50,000,000.00	$10,818	$1,098.39	+$50.00M → ENZC
2	$233,748,371,262	$233,694,859,813.08	$11,738	$1,222.51	+$233748.36M → ENZC
3	$1,021,074,511,412,696	$1,020,824,400,655,446.10	$12,774	$1,364.64	+$1021074511.40M → ENZC
4	$4,168,597,328,794,951,700	$4,167,504,779,067,739,000.00	$13,944	$1,527.86	+$4168597328794.94M → ENZC
5	$15,905,475,114,600,665,000,000	$15,901,014,715,458,854,000,000.00	$15,270	$1,715.87	+$15905475114600664.00M → ENZC
6	$56,718,938,532,531,060,000,000,000	$56,701,919,674,158,435,000,000,000.00	$16,775	$1,933.09	+$56718938532531060736.00M → ENZC
7	$189,031,807,435,623,860,000,000,000,000	$188,971,118,171,394,040,000,000,000,000.00	$18,490	$2,184.87	+$1.8903180743562385e+23M → ENZC
8	$588,799,810,476,518,260,000,000,000,000,000	$588,597,546,442,562,100,000,000,000,000,000.00	$20,450	$2,477.63	+$5.8879981047651824e+26M → ENZC
9	$1,714,064,268,114,722,600,000,000,000,000,000,000	$1,713,434,252,317,512,700,000,000,000,000,000,000.00	$22,697	$2,819.19	+$1.7140642681147225e+30M → ENZC
10	$4,663,521,010,693,878,300,000,000,000,000,000,000,000	$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00	$25,280	$3,219.02	+$4.663521010693878e+33M → ENZC

ENZC vs XYLD: Complete Analysis 2026

ENZC — Stock

Enzolytics, Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. The company has clinically tested anti-HIV therapeutics. In addition, it has created a proprietary cell line that produces human monoclonal antibodies that target and neutralizes the HIV virus. Enzolytics Inc. is based in Plano, Texas.

Full ENZC Calculator →

XYLD — ETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →

📬

Get this ENZC vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ENZC vs SCHD ENZC vs JEPI ENZC vs O ENZC vs KO ENZC vs MAIN ENZC vs QYLD ENZC vs JEPQ ENZC vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.